These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16225097)

  • 1. Enzymatic examination of potential interaction between statins or fibrates and consumed Tricholoma equestre.
    Chodorowski Z; Sein Anand J; Madaliński M; Rutkowski B; Cylkowska B; Rutkowski P; Wiśniewski M; Hajduk A
    Przegl Lek; 2005; 62(6):468-70. PubMed ID: 16225097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute poisoning with Tricholoma equestre.
    Anand JS; Chwaluk P; Sut M
    Przegl Lek; 2009; 66(6):339-40. PubMed ID: 19788144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Yellow Knight Fights Back: Toxicological, Epidemiological, and Survey Studies Defend Edibility of
    Klimaszyk P; Rzymski P
    Toxins (Basel); 2018 Nov; 10(11):. PubMed ID: 30428584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apolipoprotein modifying effects of statins and fibrate in various age groups of coronary artery disease patients.
    Sharma R; Mahajan M; Singh B; Bal BS; Kant R
    J Indian Med Assoc; 2006 Sep; 104(9):492-4, 496, 498. PubMed ID: 17388006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin/fibrate combination in patients with metabolic syndrome or diabetes: evaluating the risks of pharmacokinetic drug interactions.
    Davidson MH
    Expert Opin Drug Saf; 2006 Jan; 5(1):145-56. PubMed ID: 16370963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rosuvastatin 5 and 10 mg/d: a pilot study of the effects in hypercholesterolemic adults unable to tolerate other statins and reach LDL cholesterol goals with nonstatin lipid-lowering therapies.
    Glueck CJ; Aregawi D; Agloria M; Khalil Q; Winiarska M; Munjal J; Gogineni S; Wang P
    Clin Ther; 2006 Jun; 28(6):933-42. PubMed ID: 16860175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute poisoning with Tricholoma equestre.
    Chodorowski Z; Waldman W; Sein Anand J
    Przegl Lek; 2002; 59(4-5):386-7. PubMed ID: 12184017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Special recommendations for lipid-lowering treatment: efficacy and safety].
    Martinez TL; Nascimento HM
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():6-8. PubMed ID: 16400389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute intoxication with Tricholoma equestre--clinical course.
    Sein Anand J; Chwaluk P
    Przegl Lek; 2010; 67(8):617-8. PubMed ID: 21384788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiplatelet actions of statins and fibrates are mediated by PPARs.
    Ali FY; Armstrong PC; Dhanji AR; Tucker AT; Paul-Clark MJ; Mitchell JA; Warner TD
    Arterioscler Thromb Vasc Biol; 2009 May; 29(5):706-11. PubMed ID: 19150877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile.
    Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ
    Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluvastatin as co-medication in heart transplant recipients with elevated creatine-kinase.
    Sadoni S; Kaczmarek I; Delgado O; Schmöckel M; Reichart B; Meiser B
    Transplant Proc; 2007 Mar; 39(2):558-9. PubMed ID: 17362781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interpreting clinical trials of diabetic dyslipidaemia: new insights.
    Wierzbicki AS
    Diabetes Obes Metab; 2009 Mar; 11(3):261-70. PubMed ID: 17645560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of statins on the liver: clinical analysis of patients with ischemic stroke.
    Zhang LS; Liu ZX; Lü W; Hu XY
    Chin Med J (Engl); 2011 Mar; 124(6):897-900. PubMed ID: 21518599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Muscular exertion--"embarrassment" in the evaluation of aminotransferases and creatine kinase serum levels].
    Drnek I; Rejmanová J; Skvor J
    Cesk Pediatr; 1993 Jul; 48(7):417-8. PubMed ID: 8374980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of low-dose atorvastatin and fenofibrate in mixed hyperlipidemia.
    Chatley P; Badyal DK; Calton R; Khosla PP
    Methods Find Exp Clin Pharmacol; 2007 Apr; 29(3):217-21. PubMed ID: 17520105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indications of hepatic and cardiac toxicity caused by subchronic Tricholoma flavovirens consumption.
    Nieminen P; Kärjä V; Mustonen AM
    Food Chem Toxicol; 2008 Feb; 46(2):781-6. PubMed ID: 18055085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is it time to stop treating dyslipidaemia with fibrates?
    Benatar JR; Stewart RA
    N Z Med J; 2007 Sep; 120(1261):U2706. PubMed ID: 17853928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simvastatin for rats with thioacetamide-induced liver failure and encephalopathy.
    Huang HC; Wang SS; Lee FY; Chan CY; Chang FY; Lin HC; Chu CJ; Chen YC; Lee SD
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e236-42. PubMed ID: 17573832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.